Navigation Links
Optimal Treatment Boosts Blacks' Lung Cancer Survival

Patients who received recommended care did better, regardless of race, study found

MONDAY, Jan. 19 (HealthDay News) -- Survival disparities between white and black patients with early-stage lung cancer disappear when black patients receive optimal therapy, according to a U.S. study that included nearly 18,000 patients.

Surgery to remove a portion of the lung (pulmonary resection) provides the best chance of a cure for patients with early-stage lung cancer.

"Black patients with early-stage lung cancer have lower five-year survival rates than white patients, and this difference in outcome has been attributed to lower rates of resection among black patients," wrote Dr. Farhood Farjah, of the University of Washington, Seattle, and colleagues. "Several potential factors underlying racial differences in the receipt of surgical therapy include differences in pulmonary function, access to care, refusal of surgery, beliefs about tumor spread on air exposure at the time of operation and the possibility of cure without surgery, distrust of the health care system and physicians, suboptimal patterns of patient and physician communication and health care system and provider biases."

Access to care is often considered the most important of the factors that affect racial disparities among lung cancer patients.

The study looked at nearly 18,000 patients (89 percent white and 6 percent black) who were diagnosed with lung cancer between 1992 and 2002 and recommended for pulmonary resection.

The researchers found that 69 percent of black patients had surgery, compared with 83 percent of white patients. Five-year survival rates were similar among both black and white patients who had surgery.

"Although these findings do not refute the likely roles of health care system and provider biases and patient characteristics as important causal factors underlying health disparities, the findings do suggest that other factors (i.e., distrust, perceptions and beliefs about lung cancer and its treatment and limited access to subspecialty care) may have a more dominant role in causing disparities than previously recognized," the study authors wrote.

"The implication of these findings is that interventions designed to narrow gaps in health care should target structured aspects of care, providers and patients and communities at risk for lung cancer and suboptimal care," the team added.

The researchers suggested that referral of all patients with potentially curable lung cancer for consideration of lung resection may help reduce racial disparities in survival.

The study was published in the January issue of the journal Archives of Surgery.

More information

The U.S. National Cancer Institute has more about lung cancer.

-- Robert Preidt

SOURCE: JAMA/Archives journals, news release, Jan. 19, 2009

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Optimal systemic and splanchnic hemodynamic state after living-donor liver transplantation
2. In largest U.S. Hep C trial, researchers determine weight-based dosing is key to optimal treatment
3. Join the Vitamin D Revolution: How to Get 30 Minutes of Daily Sunshine for Optimal Health
4. Optimal band imaging with endoscopy facilitates the diagnosis of depressed-type early gastric cancer
5. Do patients with inflammatory bowel disease receive optimal care?
6. Kronos Optimal Health Company Aims to Stop Diabetes Before It Starts
7. Navigenics(TM) Launches Health Compass Service, a Personal Genetic Assessment for Optimal Health
8. Optimal Readings Appoints Operations Veteran Rita Edwards as SVP Clinical Operations
9. Optimal Readings Selected to Present at CEDs 25th Annual Venture Conference
10. Medco, Healthways Launch Center for Health Action to Deliver Optimal Health(TM)
11. eHealth Initiative and the Center for Improving Medication Management to Present Report Detailing Both Impact of E-Prescriptions on U.S. Health Care System and Guidelines for Achieving Optimal Results
Post Your Comments:
Related Image:
Optimal Treatment Boosts Blacks' Lung Cancer Survival 
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article ... of Toronto and the University of British Columbia suggested that laws requiring bicyclists to ... article explains that part of the reason for the controversial conclusion is that, while ...
(Date:11/27/2015)... ... November 27, 2015 , ... A team of Swiss doctors has ... it. Surviving Mesothelioma has just posted the findings on the website. Click here ... the cases of 136 mesothelioma patients who were treated with chemotherapy followed by EPP ...
(Date:11/27/2015)... CA (PRWEB) , ... November 27, 2015 , ... Lizzie’s ... , The company is offering customers 10% off of their purchase of lice treatment ... treatment at full price. According to a company spokesperson. “Finding lice is a sure ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... MPWH, the No.1 Herpes-only dating community in ... (see Table 1-1 ). More than 3.7 billion people under the age of ... 1 (HSV-1), according to WHO's first global estimates of HSV-1 infection . , "The ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... A simply ... Jones, is an interesting show that delves into an array of issues that are ... that could benefit from open dialogue, this show is changing the subjects consumers focus ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 ... the addition of the  "2016 Future ... Global Cell Surface Testing Market: Supplier ... to their offering.  --> ... of the  "2016 Future Horizons and ...
(Date:11/26/2015)... 26, 2015 ... of the  "2016 Future Horizons and ... Drug Monitoring (TDM) Market: Supplier Shares, ... Opportunities"  report to their offering.  ... the addition of the  "2016 Future ...
(Date:11/26/2015)... , November 26, 2015 ... of the "Radioimmunoassay Market by Type ... Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application ... Forecast to 2020" report to their ... announced the addition of the "Radioimmunoassay ...
Breaking Medicine Technology: